Cancer glossary
Metabolic response on PET-CT: complete, partial and PERCIST criteria
Metabolic response is the change in tumor FDG uptake on PET-CT after therapy. What complete and partial response mean, PERCIST cut-offs and why timing matters.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
Metabolic response is the change in tumor activity on PET-CT compared with the scan before treatment: how much less FDG the lesions take up. It adds to the size-based assessment (RECIST) rather than replacing it.
How it appears in your report
- “Complete metabolic response (CMR)” — no active tissue visible.
- “Partial metabolic response (PMR): SULpeak down by …%”.
- “Stable metabolic disease (SMD)”.
- “Progressive metabolic disease (PMD)”, “new hypermetabolic lesions”.
- “Residual metabolic activity in …” — part of a lesion still takes up FDG.
What it means
The criteria used most often are PERCIST 1.0 (2009). They are based on SULpeak, the uptake in the most active part of a lesion adjusted for lean body mass.
| Category | PERCIST criterion |
|---|---|
| Complete metabolic response | Uptake in the lesion below the liver average and at blood pool background, no new active lesions |
| Partial metabolic response | SULpeak down by at least 30% and at least 0.8 units, no new lesions |
| Stable metabolic disease | Neither response nor progression |
| Progressive metabolic disease | SULpeak up by more than 30% and by 0.8 units, a clear increase in the extent of uptake, or new lesions typical of cancer |
There are also older EORTC criteria (1999), which are likewise based on percentage change in SUV. The report usually states which system was used. A single SUVmax value without a comparison does not define a response.
Does it affect treatment
Metabolic response is weighed together with lesion size, examination and blood tests. A common trap is timing: inflammation after radiotherapy or surgery takes up FDG and can mimic tumor, while a scan done too soon after radiotherapy can sometimes underestimate activity. So when to do PET-CT and how to read it is decided by your treating doctor. If you have a PET-CT and a CT with different conclusions, I can go through them in a consultation.
Questions to ask your doctor
- Which criteria were used to assess response, and which scan was this compared with?
- Was the scan done too soon after treatment?
- If PET-CT and CT disagree, which one will we rely on?
Sources
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors — Wahl R.L. et al., Journal of Nuclear Medicine, 2009
- PET Response Criteria in Solid Tumors (PERCIST) — Radiopaedia
- The role of 18F-FDG PET/CT in monitoring tumour response — HealthManagement (Imaging Management), 2010
Watch me explain this on video
Short videos on my Instagram (in Russian)
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
